Friday 6 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.54 4.61 +1.89%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 104×
Fwd P/E: 47.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	7.39%	7.70%	4.58%	1.87%
Piotroski F-Score Full definition →		4	4	3	3
ROA Full definition →		4.50%	4.77%	2.76%	1.13%
ROIC Full definition →		5.61%	5.69%	3.11%	1.94%
Return on Tangible Assets Full definition →		14.89%	14.90%	13.08%	5.22%
Average Days of Receivables Full definition →		49.54	50.29	68.63	66.80
Free Cash Flow per Share Full definition →		13.78	16.31	17.20	11.46
Free Cash Flow Full definition →		2,019.20	2,401.30	2,540.00	1,694.40
Capital Expenditures Full definition →		(185.40)	(189.50)	(338.80)	(552.70)
Other line items
Cash ROIC Full definition →		7.12%	8.22%	9.26%	6.16%
Accounts Receivable Turnover Full definition →		7.20	5.91	5.71	6.32
Accounts Payable Turnover Full definition →		5.62	6.50	6.42	6.36
Inventory Turnover Full definition →		1.04	1.15	1.12	1.21
Average Days of Payables Full definition →		65.59	53.72	56.53	58.57
Days of Inventory on Hand Full definition →		329.16	292.04	333.72	302.75
Tax Rate Full definition →		(0.17)	(0.15)	(0.17)	(0.22)
Research and Development Expense of Revenue Full definition →		17.98%	18.95%	20.08%	20.90%
Selling, General and Administrative Expense of Revenue Full definition →		24.61%	24.84%	25.87%	26.72%
Share Based Compensation of Revenue Full definition →		2.94%	2.96%	2.95%	2.94%
Operating CF/Net income Full definition →		1.71	1.89	3.45	6.47
Depreciation/Fixed assets Full definition →		0.35	0.38	0.45	0.51
Capex/Depreciation Full definition →		(0.17)	(0.16)	(0.25)	(0.36)
Revenue per Share Full definition →		67.51	67.51	67.89	69.67
Operating CF per Share Full definition →		15.05	17.60	19.49	15.20
Capex per Share Full definition →		(1.27)	(1.29)	(2.29)	(3.74)
Capex to Sales Full definition →		0.02	0.02	0.03	0.05

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly